Riskpilot← Back to searchSign inGet full accessFalköpings vet. AB
ABActiveOrg 5593230070Bangatan 4 AVeterinary activities · NACE 7500Est. 20211-4 employees
Revenue 2025
SEK 4M
+1% vs 2024
EBITDA margin
13.7%
-51% vs 2024
Equity ratio
46.9%
Financial strength
Net profit 2025
SEK 248K
-55% vs 2024
| Revenue | SEK 4M | +1% |
| EBITDA | SEK 547K | -51% |
| Net profit | SEK 248K | -55% |
| Total assets | SEK 4,3M | +36% |
| Equity | SEK 2M | +14% |
| Employees | — | — |
Legal name
Falköpings vet. AB
Org number
5593230070
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
16 juni 2021
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva djurklinik samt försäljning av djurfoder och övriga djurtillbehör.
Address
Bangatan 4 A
Email
marwan-aljubouri@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 4 335 | 4 396 | 3 941 | 3 998 |
| Staff expenses | — | — | — | −1 436 |
| EBITDA | 1 673 | 848 | 1 124 | 547 |
| Depreciation & amort. | −6 | −125 | −152 | −192 |
| EBIT | 1 667 | 723 | 972 | 355 |
| Net financials | −1 | −16 | −29 | −32 |
| Profit before tax | 1 266 | 462 | 699 | 322 |
| Tax | −271 | −100 | −152 | 74 |
| Net profit | 995 | 362 | 547 | 248 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 242 | 3 180 | 3 169 | 4 309 |
| Equity | 1 045 | 1 227 | 1 774 | 2 022 |
| Long-term debt | 22 | 302 | 167 | 659 |
| Short-term debt | 775 | 1 006 | 338 | 738 |
| Total debt | 797 | 1 308 | 505 | 1 397 |
EBITDA margin
13.7%
This company
15.8%
Market median
-13% vs market
20222025
Equity ratio
46.9%
This company
38.2%
Market median
+23% vs market
20222025
Return on equity
12.3%
This company
18.4%
Market median
+33% vs market
20222025
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20222025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20222025
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NI Chief Executive Officer | Chief Executive Officer | 2022 |
MS Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Falköpings vet. AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Ibrahim Albadran | Chief Executive Officer | 0 companies |
| Marwan Shaalan Aljubouri | Chief Executive Officer | 0 companies |